Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [751]

Treating liver metastases in colorectal cancer

Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany

Treating liver metastases in colorectal cancer ( Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany )

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA

Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )

Gefitinib versus placebo in oesophageal cancer progressing after chemotherapy

Prof David Ferry - New Cross Hospital, Wolverhampton, UK

Gefitinib versus placebo in oesophageal cancer progressing after chemotherapy ( Prof David Ferry - New Cross Hospital, Wolverhampton, UK )

The role of genomic tests in personalised medicine for colon cancer

Prof David Kerr - Oxford Clinical Trials Research Unit, Oxford, UK

The role of genomic tests in personalised medicine for colon cancer ( Prof David Kerr - Oxford Clinical Trials Research Unit, Oxford, UK )

Gastric cancer in Japan

Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan

Gastric cancer in Japan ( Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan )

Genetic signatures for colon cancer

Prof Pierre Laurent-Puig - University of Paris, France

Genetic signatures for colon cancer ( Prof Pierre Laurent-Puig - University of Paris, France )

Colorectal cancer in the elderly

Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus

Colorectal cancer in the elderly ( Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus )

The EUREKA Initiative

Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands

The EUREKA Initiative ( Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands )

Prevention best ‘treatment’ for colon cancer

Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center, Israel

Prevention best ‘treatment’ for colon cancer ( Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center, Israel )

Bevacizumab benefits beyond progression in TML study subgroups

Dr Thierry André – Hôpital Saint Antoine, Paris, France

Bevacizumab benefits beyond progression in TML study subgroups ( Dr Thierry André – Hôpital Saint Antoine, Paris, France )

Pharmacodynamic endpoints need to be included in GI trials

Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy

Pharmacodynamic endpoints need to be included in GI trials ( Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy )

Exploring new targets in GI cancer

Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Exploring new targets in GI cancer ( Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain )

More from ecancer